ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds Biogen Q1 2026 Earnings Strong EPS Surprise of 2634 Boosts Investor Confidence OnKure Therapeutics Inc OKUR Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline TG Therapeutics Q1 2026 Earnings EPS Disappoints as Stock Declines TTWO Q1 2026 Earnings Earnings Beat Fails to Lift Shares as Market Digests Outlook ATHR Q1 2026 Earnings NarrowerThanExpected Loss Signals Improved Cost Management